Literature DB >> 29077691

Preclinical mouse solid tumour models: status quo, challenges and perspectives.

Nicolas Gengenbacher1, Mahak Singhal1,2, Hellmut G Augustin1,2,3.   

Abstract

Oncology research in humans is limited to analytical and observational studies for obvious ethical reasons, with therapy-focused clinical trials being the one exception to this rule. Preclinical mouse tumour models therefore serve as an indispensable intermediate experimental model system bridging more reductionist in vitro research with human studies. Based on a systematic survey of preclinical mouse tumour studies published in eight scientific journals in 2016, this Analysis provides an overview of how contemporary preclinical mouse tumour biology research is pursued. It thereby identifies some of the most important challenges in this field and discusses potential ways in which preclinical mouse tumour models could be improved for better relevance, reproducibility and translatability.

Entities:  

Mesh:

Year:  2017        PMID: 29077691     DOI: 10.1038/nrc.2017.92

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  158 in total

1.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

Review 2.  Mouse models of advanced spontaneous metastasis for experimental therapeutics.

Authors:  Giulio Francia; William Cruz-Munoz; Shan Man; Ping Xu; Robert S Kerbel
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

3.  Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Authors:  Eric Raymond; Laetitia Dahan; Jean-Luc Raoul; Yung-Jue Bang; Ivan Borbath; Catherine Lombard-Bohas; Juan Valle; Peter Metrakos; Denis Smith; Aaron Vinik; Jen-Shi Chen; Dieter Hörsch; Pascal Hammel; Bertram Wiedenmann; Eric Van Cutsem; Shem Patyna; Dongrui Ray Lu; Carolyn Blanckmeister; Richard Chao; Philippe Ruszniewski
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

Review 4.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

5.  Development and economic trends in cancer therapeutic drugs: a 5-year update 2010-2014.

Authors:  P Savage; S Mahmoud
Journal:  Br J Cancer       Date:  2015-03-17       Impact factor: 7.640

6.  Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer.

Authors:  Yoon Young Choi; Jae Eun Lee; Hyunki Kim; Moon Hee Sim; Ka-Kyung Kim; Gunho Lee; Hyoung-Il Kim; Ji Yeong An; Woo Jin Hyung; Choong-Bai Kim; Sung Hoon Noh; Sangwoo Kim; Jae-Ho Cheong
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

7.  XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer.

Authors:  J J Morton; G Bird; S B Keysar; D P Astling; T R Lyons; R T Anderson; M J Glogowska; P Estes; J R Eagles; P N Le; G Gan; B McGettigan; P Fernandez; N Padilla-Just; M Varella-Garcia; J I Song; D W Bowles; P Schedin; A-C Tan; D R Roop; X-J Wang; Y Refaeli; A Jimeno
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

8.  In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis.

Authors:  Jatin Roper; Tuomas Tammela; Naniye Malli Cetinbas; Adam Akkad; Ali Roghanian; Steffen Rickelt; Mohammad Almeqdadi; Katherine Wu; Matthias A Oberli; Francisco J Sánchez-Rivera; Yoona K Park; Xu Liang; George Eng; Martin S Taylor; Roxana Azimi; Dmitriy Kedrin; Rachit Neupane; Semir Beyaz; Ewa T Sicinska; Yvelisse Suarez; James Yoo; Lillian Chen; Lawrence Zukerberg; Pekka Katajisto; Vikram Deshpande; Adam J Bass; Philip N Tsichlis; Jacqueline Lees; Robert Langer; Richard O Hynes; Jianzhu Chen; Arjun Bhutkar; Tyler Jacks; Ömer H Yilmaz
Journal:  Nat Biotechnol       Date:  2017-05-01       Impact factor: 54.908

Review 9.  Oestrogen exposure and breast cancer risk.

Authors:  Ruth C Travis; Timothy J Key
Journal:  Breast Cancer Res       Date:  2003-07-28       Impact factor: 6.466

View more
  80 in total

Review 1.  A Blazing Landscape: Neuroinflammation Shapes Brain Metastasis.

Authors:  Hila Doron; Tobias Pukrop; Neta Erez
Journal:  Cancer Res       Date:  2019-01-24       Impact factor: 12.701

Review 2.  Perspective: pathobiological paradigms in pulmonary hypertension, time for reappraisal.

Authors:  Rubin M Tuder; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-18       Impact factor: 5.464

3.  Universal scaling laws rule explosive growth in human cancers.

Authors:  Víctor M Pérez-García; Gabriel F Calvo; Jesús J Bosque; Odelaisy León-Triana; Juan Jiménez; Julián Perez-Beteta; Juan Belmonte-Beitia; Manuel Valiente; Lucía Zhu; Pedro García-Gómez; Pilar Sánchez-Gómez; Esther Hernández-San Miguel; Rafael Hortigüela; Youness Azimzade; David Molina-García; Álvaro Martinez; Ángel Acosta Rojas; Ana Ortiz de Mendivil; Francois Vallette; Philippe Schucht; Michael Murek; María Pérez-Cano; David Albillo; Antonio F Honguero Martínez; Germán A Jiménez Londoño; Estanislao Arana; Ana M García Vicente
Journal:  Nat Phys       Date:  2020-08-10       Impact factor: 20.034

Review 4.  Zebrafish patient avatars in cancer biology and precision cancer therapy.

Authors:  Maurizio Fazio; Julien Ablain; Yan Chuan; David M Langenau; Leonard I Zon
Journal:  Nat Rev Cancer       Date:  2020-04-06       Impact factor: 60.716

5.  Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma.

Authors:  Eric R Molina; Letitia K Chim; Sergio Barrios; Joseph A Ludwig; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2020-02-14       Impact factor: 6.389

Review 6.  Personalized Cancer Models for Target Discovery and Precision Medicine.

Authors:  Carla Grandori; Christopher J Kemp
Journal:  Trends Cancer       Date:  2018-08-08

7.  Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma.

Authors:  Nuchjira Takheaw; Gunya Sittithumcharee; Ryusho Kariya; Watchara Kasinrerk; Seiji Okada
Journal:  Cancer Immunol Immunother       Date:  2020-11-19       Impact factor: 6.968

8.  EACR-MRS conference on Seed and Soil: In Vivo Models of Metastasis.

Authors:  I Teles Alves; N Cohen; P G Ersan; R Eyre; I Godet; D Holovanchuk; R Jackstadt; L Kyjacova; K Mahal; A Noguera-Castells; L Recalde-Percaz; J P Sleeman
Journal:  Clin Exp Metastasis       Date:  2018-03-27       Impact factor: 5.150

Review 9.  Breast cancer models: Engineering the tumor microenvironment.

Authors:  Gokhan Bahcecioglu; Gozde Basara; Bradley W Ellis; Xiang Ren; Pinar Zorlutuna
Journal:  Acta Biomater       Date:  2020-02-09       Impact factor: 8.947

10.  Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors.

Authors:  Caroline E Porter; Amanda Rosewell Shaw; Youngrock Jung; Tiffany Yip; Patricia D Castro; Vlad C Sandulache; Andrew Sikora; Stephen Gottschalk; Michael M Ittman; Malcolm K Brenner; Masataka Suzuki
Journal:  Mol Ther       Date:  2020-02-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.